These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22576253)

  • 1. Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFβ receptor type II mice.
    Tsuda M; Zhang W; Yang GX; Tsuneyama K; Ando Y; Kawata K; Park O; Leung PS; Coppel RL; Ansari AA; Ridgway WM; Gao B; Lian ZX; Flavell R; He XS; Gershwin ME
    Hepatology; 2013 Feb; 57(2):806-16. PubMed ID: 22576253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice.
    Yoshida K; Yang GX; Zhang W; Tsuda M; Tsuneyama K; Moritoki Y; Ansari AA; Okazaki K; Lian ZX; Coppel RL; Mackay IR; Gershwin ME
    Hepatology; 2009 Nov; 50(5):1494-500. PubMed ID: 19676134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.
    Yang GX; Lian ZX; Chuang YH; Moritoki Y; Lan RY; Wakabayashi K; Ansari AA; Flavell RA; Ridgway WM; Coppel RL; Tsuneyama K; Mackay IR; Gershwin ME
    Hepatology; 2008 Jun; 47(6):1974-82. PubMed ID: 18452147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis.
    Kawata K; Tsuda M; Yang GX; Zhang W; Tanaka H; Tsuneyama K; Leung P; He XS; Knechtle S; Ansari AA; Coppel RL; Gershwin ME
    PLoS One; 2013; 8(9):e74225. PubMed ID: 24040208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer T cells exacerbate liver injury in a transforming growth factor beta receptor II dominant-negative mouse model of primary biliary cirrhosis.
    Chuang YH; Lian ZX; Yang GX; Shu SA; Moritoki Y; Ridgway WM; Ansari AA; Kronenberg M; Flavell RA; Gao B; Gershwin ME
    Hepatology; 2008 Feb; 47(2):571-80. PubMed ID: 18098320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice.
    Ando Y; Yang GX; Tsuda M; Kawata K; Zhang W; Nakajima T; Tsuneyama K; Leung P; Lian ZX; Okazaki K; Ridgway WM; Norman GL; Ansari AA; He XS; Coppel RL; Gershwin ME
    Hepatology; 2012 Oct; 56(4):1418-26. PubMed ID: 22532156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFβRII mice.
    Kawata K; Yang GX; Ando Y; Tanaka H; Zhang W; Kobayashi Y; Tsuneyama K; Leung PS; Lian ZX; Ridgway WM; Ansari AA; He XS; Gershwin ME
    Hepatology; 2013 Sep; 58(3):1094-104. PubMed ID: 23532950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis.
    Zhang W; Tsuda M; Yang GX; Tsuneyama K; Rong G; Ridgway WM; Ansari AA; Flavell RA; Coppel RL; Lian ZX; Gershwin ME
    Hepatology; 2010 Jul; 52(1):215-22. PubMed ID: 20578264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2Rα(-/-) mice.
    Yao Y; Yang W; Yang YQ; Ma HD; Lu FT; Li L; Tao YY; Tsuneyama K; Zhang W; Friedman S; Gershwin ME; Lian ZX
    J Autoimmun; 2014 Jun; 51():99-108. PubMed ID: 24651036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells.
    Huang W; Kachapati K; Adams D; Wu Y; Leung PS; Yang GX; Zhang W; Ansari AA; Flavell RA; Gershwin ME; Ridgway WM
    J Autoimmun; 2014 May; 50():123-34. PubMed ID: 24556277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy.
    Yang CY; Ma X; Tsuneyama K; Huang S; Takahashi T; Chalasani NP; Bowlus CL; Yang GX; Leung PS; Ansari AA; Wu L; Coppel RL; Gershwin ME
    Hepatology; 2014 May; 59(5):1944-53. PubMed ID: 24375552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice.
    Oertelt S; Lian ZX; Cheng CM; Chuang YH; Padgett KA; He XS; Ridgway WM; Ansari AA; Coppel RL; Li MO; Flavell RA; Kronenberg M; Mackay IR; Gershwin ME
    J Immunol; 2006 Aug; 177(3):1655-60. PubMed ID: 16849474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination.
    Gran B; Zhang GX; Yu S; Li J; Chen XH; Ventura ES; Kamoun M; Rostami A
    J Immunol; 2002 Dec; 169(12):7104-10. PubMed ID: 12471147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis.
    Wang YH; Yang W; Yang JB; Jia YJ; Tang W; Gershwin ME; Ridgway WM; Lian ZX
    J Autoimmun; 2015 May; 59():26-37. PubMed ID: 25701076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells.
    Liaskou E; Patel SR; Webb G; Bagkou Dimakou D; Akiror S; Krishna M; Mells G; Jones DE; Bowman SJ; Barone F; Fisher BA; Hirschfield GM
    J Autoimmun; 2018 Nov; 94():143-155. PubMed ID: 30119881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel p40-independent function of IL-12p35 is required for progression and maintenance of herpes stromal keratitis.
    Frank GM; Divito SJ; Maker DM; Xu M; Hendricks RL
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3591-8. PubMed ID: 20207959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse model of primary biliary cirrhosis with progressive fibrosis: are we there yet?
    Popov Y
    Hepatology; 2013 Feb; 57(2):429-31. PubMed ID: 22815060
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression and Function of IL12/23 Related Cytokine Subunits (p35, p40, and p19) in Giant-Cell Arteritis Lesions: Contribution of p40 to Th1- and Th17-Mediated Inflammatory Pathways.
    Espígol-Frigolé G; Planas-Rigol E; Lozano E; Corbera-Bellalta M; Terrades-García N; Prieto-González S; García-Martínez A; Hernández-Rodríguez J; Grau JM; Cid MC
    Front Immunol; 2018; 9():809. PubMed ID: 29731755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A profibrotic function of IL-12p40 in experimental pulmonary fibrosis.
    Huaux F; Arras M; Tomasi D; Barbarin V; Delos M; Coutelier JP; Vink A; Phan SH; Renauld JC; Lison D
    J Immunol; 2002 Sep; 169(5):2653-61. PubMed ID: 12193738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis.
    Moritoki Y; Zhang W; Tsuneyama K; Yoshida K; Wakabayashi K; Yang GX; Bowlus C; Ridgway WM; Ueno Y; Ansari AA; Coppel RL; Mackay IR; Flavell RA; Gershwin ME; Lian ZX
    Gastroenterology; 2009 Mar; 136(3):1037-47. PubMed ID: 19118554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.